News & Events about Nautilus Biotechnology Inc.
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B. Riley Securities Disruptive Biotech Enabling Technologies ...
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming 43rd Annual Cowen Health Care Conference. Nautilus management is ...
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, ...
Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome
Nautilus Biotechnology - San Diego
University Town Center in San Diego, California
Nick Nelson
SVP and Chief Business Officer
SEATTLE, ...
Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus next-generation proteome analysis platform to advance the study of a rare childhood cancerSEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company ...